It was also confirmed that FXR can ensure that intestinal barrier function is maintained, preventing the formation of gallstones and reducing liver cholestasis, which may be based on the regulation of related genes affecting bile acid detoxification and drug metabolism by FXR (Norona et al., 2020). The gene discussed is NR1H4; the disease is gallstones.